How Innovations Are Driving the Human Microbiome Market Forward
The Human Microbiome Market is experiencing remarkable growth, fueled by continuous innovations. According to Stratview Research, the market was valued at US$ 520.5 million in 2020 and is expected to reach US$ 1783.9 million by 2026, growing at a robust CAGR of 23.2% during 2021-2026. Innovations in microbiome-based therapies, probiotics, and diagnostics are key drivers behind this surge. North America leads the market, projected to maintain strong growth throughout the assessment period.